 | • レポートコード：GIR-105X07773 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Chemical & Material |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、腫瘍治療用遺伝子治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。腫瘍治療用遺伝子治療の種類別市場規模（遺伝子誘導免疫療法、腫瘍溶解性ウイルス療法、遺伝子導入）、用途別市場規模（病院、クリニック、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・腫瘍治療用遺伝子治療の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Novartis、Kite Pharma、Amgen、Shanghai Sunway、Sibiono ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：遺伝子誘導免疫療法、腫瘍溶解性ウイルス療法、遺伝子導入 ・用途別分析2016年-2026年：病院、クリニック、その他 ・腫瘍治療用遺伝子治療の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・腫瘍治療用遺伝子治療のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・腫瘍治療用遺伝子治療のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・腫瘍治療用遺伝子治療の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・腫瘍治療用遺伝子治療の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Gene Therapies for Tumor Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Gene Therapies for Tumor Treatment size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Gene Therapies for Tumor Treatment market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Gene Therapies for Tumor Treatment market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Gene Induced Immunotherapy
Oncolytic Virotherapy
Gene Transfer
Market segment by Application can be divided into
Hospital
Clinic
Other
The key market players for global Gene Therapies for Tumor Treatment market are listed below:
Novartis
Kite Pharma
Amgen
Shanghai Sunway
Sibiono
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Gene Therapies for Tumor Treatment Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Gene Therapies for Tumor Treatment Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Gene Induced Immunotherapy
1.2.3 Oncolytic Virotherapy
1.2.4 Gene Transfer
1.3 Market Analysis by Application
1.3.1 Overview: Global Gene Therapies for Tumor Treatment Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Gene Therapies for Tumor Treatment Market Size & Forecast
1.4.1 Global Gene Therapies for Tumor Treatment Sales in Value (2016-2026))
1.4.2 Global Gene Therapies for Tumor Treatment Sales in Volume (2016-2026)
1.4.3 Global Gene Therapies for Tumor Treatment Price by Type (2016-2026) & (USD/Unit)
1.5 Global Gene Therapies for Tumor Treatment Production Capacity Analysis
1.5.1 Global Gene Therapies for Tumor Treatment Total Production Capacity (2016-2026)
1.5.2 Global Gene Therapies for Tumor Treatment Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Gene Therapies for Tumor Treatment Market Drivers
1.6.2 Gene Therapies for Tumor Treatment Market Restraints
1.6.3 Gene Therapies for Tumor Treatment Trends Analysis
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis Gene Therapies for Tumor Treatment Product and Services
2.1.4 Novartis Gene Therapies for Tumor Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Kite Pharma
2.2.1 Kite Pharma Details
2.2.2 Kite Pharma Major Business
2.2.3 Kite Pharma Gene Therapies for Tumor Treatment Product and Services
2.2.4 Kite Pharma Gene Therapies for Tumor Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Amgen
2.3.1 Amgen Details
2.3.2 Amgen Major Business
2.3.3 Amgen Gene Therapies for Tumor Treatment Product and Services
2.3.4 Amgen Gene Therapies for Tumor Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Shanghai Sunway
2.4.1 Shanghai Sunway Details
2.4.2 Shanghai Sunway Major Business
2.4.3 Shanghai Sunway Gene Therapies for Tumor Treatment Product and Services
2.4.4 Shanghai Sunway Gene Therapies for Tumor Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Sibiono
2.5.1 Sibiono Details
2.5.2 Sibiono Major Business
2.5.3 Sibiono Gene Therapies for Tumor Treatment Product and Services
2.5.4 Sibiono Gene Therapies for Tumor Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Gene Therapies for Tumor Treatment Sales by Manufacturer
3.1 Global Gene Therapies for Tumor Treatment Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Gene Therapies for Tumor Treatment Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Gene Therapies for Tumor Treatment
3.4 Market Concentration Rate
3.4.1 Top 3 Gene Therapies for Tumor Treatment Manufacturer Market Share
3.4.2 Top 6 Gene Therapies for Tumor Treatment Manufacturer Market Share
3.5 Global Gene Therapies for Tumor Treatment Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Gene Therapies for Tumor Treatment Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Gene Therapies for Tumor Treatment Market Size by Region
4.1.1 Global Gene Therapies for Tumor Treatment Sales in Volume by Region (2016-2026)
4.1.2 Global Gene Therapies for Tumor Treatment Revenue by Region (2016-2026)
4.2 North America Gene Therapies for Tumor Treatment Revenue (2016-2026)
4.3 Europe Gene Therapies for Tumor Treatment Revenue (2016-2026)
4.4 Asia-Pacific Gene Therapies for Tumor Treatment Revenue (2016-2026)
4.5 South America Gene Therapies for Tumor Treatment Revenue (2016-2026)
4.6 Middle East and Africa Gene Therapies for Tumor Treatment Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Gene Therapies for Tumor Treatment Sales in Volume by Type (2016-2026)
5.2 Global Gene Therapies for Tumor Treatment Revenue by Type (2016-2026)
5.3 Global Gene Therapies for Tumor Treatment Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Gene Therapies for Tumor Treatment Sales in Volume by Application (2016-2026)
6.2 Global Gene Therapies for Tumor Treatment Revenue by Application (2016-2026)
6.3 Global Gene Therapies for Tumor Treatment Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Gene Therapies for Tumor Treatment Sales by Type (2016-2026)
7.2 North America Gene Therapies for Tumor Treatment Sales by Application (2016-2026)
7.3 North America Gene Therapies for Tumor Treatment Market Size by Country
7.3.1 North America Gene Therapies for Tumor Treatment Sales in Volume by Country (2016-2026)
7.3.2 North America Gene Therapies for Tumor Treatment Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Gene Therapies for Tumor Treatment Sales by Type (2016-2026)
8.2 Europe Gene Therapies for Tumor Treatment Sales by Application (2016-2026)
8.3 Europe Gene Therapies for Tumor Treatment Market Size by Country
8.3.1 Europe Gene Therapies for Tumor Treatment Sales in Volume by Country (2016-2026)
8.3.2 Europe Gene Therapies for Tumor Treatment Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Gene Therapies for Tumor Treatment Sales by Type (2016-2026)
9.2 Asia-Pacific Gene Therapies for Tumor Treatment Sales by Application (2016-2026)
9.3 Asia-Pacific Gene Therapies for Tumor Treatment Market Size by Region
9.3.1 Asia-Pacific Gene Therapies for Tumor Treatment Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Gene Therapies for Tumor Treatment Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Gene Therapies for Tumor Treatment Sales by Type (2016-2026)
10.2 South America Gene Therapies for Tumor Treatment Sales by Application (2016-2026)
10.3 South America Gene Therapies for Tumor Treatment Market Size by Country
10.3.1 South America Gene Therapies for Tumor Treatment Sales in Volume by Country (2016-2026)
10.3.2 South America Gene Therapies for Tumor Treatment Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Gene Therapies for Tumor Treatment Sales by Type (2016-2026)
11.2 Middle East & Africa Gene Therapies for Tumor Treatment Sales by Application (2016-2026)
11.3 Middle East & Africa Gene Therapies for Tumor Treatment Market Size by Country
11.3.1 Middle East & Africa Gene Therapies for Tumor Treatment Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Gene Therapies for Tumor Treatment Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Gene Therapies for Tumor Treatment Typical Distributors
12.3 Gene Therapies for Tumor Treatment Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Gene Therapies for Tumor Treatment Revenue by Type, (USD Million), 2021-2026
Table 2. Global Gene Therapies for Tumor Treatment Revenue by Application, (USD Million), 2021-2026
Table 3. Novartis Basic Information, Manufacturing Base and Competitors
Table 4. Novartis Major Business
Table 5. Novartis Gene Therapies for Tumor Treatment Product and Services
Table 6. Novartis Gene Therapies for Tumor Treatment Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Kite Pharma Basic Information, Manufacturing Base and Competitors
Table 8. Kite Pharma Major Business
Table 9. Kite Pharma Gene Therapies for Tumor Treatment Product and Services
Table 10. Kite Pharma Gene Therapies for Tumor Treatment Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Amgen Basic Information, Manufacturing Base and Competitors
Table 12. Amgen Major Business
Table 13. Amgen Gene Therapies for Tumor Treatment Product and Services
Table 14. Amgen Gene Therapies for Tumor Treatment Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Shanghai Sunway Basic Information, Manufacturing Base and Competitors
Table 16. Shanghai Sunway Major Business
Table 17. Shanghai Sunway Gene Therapies for Tumor Treatment Product and Services
Table 18. Shanghai Sunway Gene Therapies for Tumor Treatment Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Sibiono Basic Information, Manufacturing Base and Competitors
Table 20. Sibiono Major Business
Table 21. Sibiono Gene Therapies for Tumor Treatment Product and Services
Table 22. Sibiono Gene Therapies for Tumor Treatment Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Global Gene Therapies for Tumor Treatment Sales by Manufacturer (2019-2021e) & (K Units)
Table 24. Global Gene Therapies for Tumor Treatment Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 25. Market Position of Manufacturers in Gene Therapies for Tumor Treatment, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 26. Global Gene Therapies for Tumor Treatment Production Capacity by Company, (K Units): 2020 VS 2021
Table 27. Head Office and Gene Therapies for Tumor Treatment Production Site of Key Manufacturer
Table 28. Global Gene Therapies for Tumor Treatment Sales by Region (2016-2021e) & (K Units)
Table 29. Global Gene Therapies for Tumor Treatment Sales by Region (2021-2026) & (K Units)
Table 30. Global Gene Therapies for Tumor Treatment Revenue by Region (2016-2021e) & (USD Million)
Table 31. Global Gene Therapies for Tumor Treatment Revenue by Region (2021-2026) & (USD Million)
Table 32. Global Gene Therapies for Tumor Treatment Sales by Type (2016-2021e) & (K Units)
Table 33. Global Gene Therapies for Tumor Treatment Sales by Type (2021-2026) & (K Units)
Table 34. Global Gene Therapies for Tumor Treatment Revenue by Type (2016-2021e) & (USD Million)
Table 35. Global Gene Therapies for Tumor Treatment Revenue by Type (2021-2026) & (USD Million)
Table 36. Global Gene Therapies for Tumor Treatment Price by Type (2016-2021e) & (USD/Unit)
Table 37. Global Gene Therapies for Tumor Treatment Price by Type (2021-2026) & (USD/Unit)
Table 38. Global Gene Therapies for Tumor Treatment Sales by Application (2016-2021e) & (K Units)
Table 39. Global Gene Therapies for Tumor Treatment Sales by Application (2021-2026) & (K Units)
Table 40. Global Gene Therapies for Tumor Treatment Revenue by Application (2016-2021e) & (USD Million)
Table 41. Global Gene Therapies for Tumor Treatment Revenue by Application (2021-2026) & (USD Million)
Table 42. Global Gene Therapies for Tumor Treatment Price by Application (2016-2021e) & (USD/Unit)
Table 43. Global Gene Therapies for Tumor Treatment Price by Application (2021-2026) & (USD/Unit)
Table 44. North America Gene Therapies for Tumor Treatment Sales by Country (2016-2021e) & (K Units)
Table 45. North America Gene Therapies for Tumor Treatment Sales by Country (2021-2026) & (K Units)
Table 46. North America Gene Therapies for Tumor Treatment Revenue by Country (2016-2021e) & (USD Million)
Table 47. North America Gene Therapies for Tumor Treatment Revenue by Country (2021-2026) & (USD Million)
Table 48. North America Gene Therapies for Tumor Treatment Sales by Type (2016-2021e) & (K Units)
Table 49. North America Gene Therapies for Tumor Treatment Sales by Type (2021-2026) & (K Units)
Table 50. North America Gene Therapies for Tumor Treatment Sales by Application (2016-2021e) & (K Units)
Table 51. North America Gene Therapies for Tumor Treatment Sales by Application (2021-2026) & (K Units)
Table 52. Europe Gene Therapies for Tumor Treatment Sales by Country (2016-2021e) & (K Units)
Table 53. Europe Gene Therapies for Tumor Treatment Sales by Country (2021-2026) & (K Units)
Table 54. Europe Gene Therapies for Tumor Treatment Revenue by Country (2016-2021e) & (USD Million)
Table 55. Europe Gene Therapies for Tumor Treatment Revenue by Country (2021-2026) & (USD Million)
Table 56. Europe Gene Therapies for Tumor Treatment Sales by Type (2016-2021e) & (K Units)
Table 57. Europe Gene Therapies for Tumor Treatment Sales by Type (2021-2026) & (K Units)
Table 58. Europe Gene Therapies for Tumor Treatment Sales by Application (2016-2021e) & (K Units)
Table 59. Europe Gene Therapies for Tumor Treatment Sales by Application (2021-2026) & (K Units)
Table 60. Asia-Pacific Gene Therapies for Tumor Treatment Sales by Region (2016-2021e) & (K Units)
Table 61. Asia-Pacific Gene Therapies for Tumor Treatment Sales by Region (2021-2026) & (K Units)
Table 62. Asia-Pacific Gene Therapies for Tumor Treatment Revenue by Region (2016-2021e) & (USD Million)
Table 63. Asia-Pacific Gene Therapies for Tumor Treatment Revenue by Region (2021-2026) & (USD Million)
Table 64. Asia-Pacific Gene Therapies for Tumor Treatment Sales by Type (2016-2021e) & (K Units)
Table 65. Asia-Pacific Gene Therapies for Tumor Treatment Sales by Type (2021-2026) & (K Units)
Table 66. Asia-Pacific Gene Therapies for Tumor Treatment Sales by Application (2016-2021e) & (K Units)
Table 67. Asia-Pacific Gene Therapies for Tumor Treatment Sales by Application (2021-2026) & (K Units)
Table 68. South America Gene Therapies for Tumor Treatment Sales by Country (2016-2021e) & (K Units)
Table 69. South America Gene Therapies for Tumor Treatment Sales by Country (2021-2026) & (K Units)
Table 70. South America Gene Therapies for Tumor Treatment Revenue by Country (2016-2021e) & (USD Million)
Table 71. South America Gene Therapies for Tumor Treatment Revenue by Country (2021-2026) & (USD Million)
Table 72. South America Gene Therapies for Tumor Treatment Sales by Type (2016-2021e) & (K Units)
Table 73. South America Gene Therapies for Tumor Treatment Sales by Type (2021-2026) & (K Units)
Table 74. South America Gene Therapies for Tumor Treatment Sales by Application (2016-2021e) & (K Units)
Table 75. South America Gene Therapies for Tumor Treatment Sales by Application (2021-2026) & (K Units)
Table 76. Middle East & Africa Gene Therapies for Tumor Treatment Sales by Country (2016-2021e) & (K Units)
Table 77. Middle East & Africa Gene Therapies for Tumor Treatment Sales by Country (2021-2026) & (K Units)
Table 78. Middle East & Africa Gene Therapies for Tumor Treatment Revenue by Country (2016-2021e) & (USD Million)
Table 79. Middle East & Africa Gene Therapies for Tumor Treatment Revenue by Country (2021-2026) & (USD Million)
Table 80. Middle East & Africa Gene Therapies for Tumor Treatment Sales by Type (2016-2021e) & (K Units)
Table 81. Middle East & Africa Gene Therapies for Tumor Treatment Sales by Type (2021-2026) & (K Units)
Table 82. Middle East & Africa Gene Therapies for Tumor Treatment Sales by Application (2016-2021e) & (K Units)
Table 83. Middle East & Africa Gene Therapies for Tumor Treatment Sales by Application (2021-2026) & (K Units)
Table 84. Direct Channel Pros & Cons
Table 85. Indirect Channel Pros & Cons
Table 86. Gene Therapies for Tumor Treatment Typical Distributors
Table 87. Gene Therapies for Tumor Treatment Typical Customers
List of Figures
Figure 1. Gene Therapies for Tumor Treatment Picture
Figure 2. Global Gene Therapies for Tumor Treatment Sales Market Share by Type in 2020
Figure 3. Gene Induced Immunotherapy
Figure 4. Oncolytic Virotherapy
Figure 5. Gene Transfer
Figure 6. Global Gene Therapies for Tumor Treatment Sales Market Share by Application in 2020
Figure 7. Hospital
Figure 8. Clinic
Figure 9. Other
Figure 10. Global Gene Therapies for Tumor Treatment Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 11. Global Gene Therapies for Tumor Treatment Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. United States Gene Therapies for Tumor Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Canada Gene Therapies for Tumor Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Mexico Gene Therapies for Tumor Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Germany Gene Therapies for Tumor Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. France Gene Therapies for Tumor Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. United Kingdom Gene Therapies for Tumor Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Russia Gene Therapies for Tumor Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Italy Gene Therapies for Tumor Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. China Gene Therapies for Tumor Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Japan Gene Therapies for Tumor Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Korea Gene Therapies for Tumor Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. India Gene Therapies for Tumor Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Southeast Asia Gene Therapies for Tumor Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Australia Gene Therapies for Tumor Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Brazil Gene Therapies for Tumor Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Egypt Gene Therapies for Tumor Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Saudi Arabia Gene Therapies for Tumor Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. South Africa Gene Therapies for Tumor Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Turkey Gene Therapies for Tumor Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Global Gene Therapies for Tumor Treatment Sales (2016-2026) & (K Units)
Figure 32. Global Gene Therapies for Tumor Treatment Production Capacity (2016-2026) & (K Units)
Figure 33. Global Gene Therapies for Tumor Treatment Production Capacity by Geographic Region: 2020 VS 2021
Figure 34. Gene Therapies for Tumor Treatment Market Drivers
Figure 35. Gene Therapies for Tumor Treatment Market Restraints
Figure 36. Gene Therapies for Tumor Treatment Market Trends
Figure 37. Global Gene Therapies for Tumor Treatment Sales Market Share by Manufacturer in 2020
Figure 38. Global Gene Therapies for Tumor Treatment Revenue Market Share by Manufacturer in 2020
Figure 39. Gene Therapies for Tumor Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 40. Top 3 Gene Therapies for Tumor Treatment Manufacturer (Revenue) Market Share in 2020
Figure 41. Top 6 Gene Therapies for Tumor Treatment Manufacturer (Revenue) Market Share in 2020
Figure 42. Global Gene Therapies for Tumor Treatment Sales Market Share by Region (2016-2026)
Figure 43. Global Gene Therapies for Tumor Treatment Revenue Market Share by Region (2016-2026)
Figure 44. North America Gene Therapies for Tumor Treatment Revenue (2016-2026) & (USD Million)
Figure 45. Europe Gene Therapies for Tumor Treatment Revenue (2016-2026) & (USD Million)
Figure 46. Asia-Pacific Gene Therapies for Tumor Treatment Revenue (2016-2026) & (USD Million)
Figure 47. South America Gene Therapies for Tumor Treatment Revenue (2016-2026) & (USD Million)
Figure 48. Middle East & Africa Gene Therapies for Tumor Treatment Revenue (2016-2026) & (USD Million)
Figure 49. Global Gene Therapies for Tumor Treatment Sales Market Share by Type (2016-2026)
Figure 50. Global Gene Therapies for Tumor Treatment Revenue Market Share by Type (2016-2026)
Figure 51. Global Gene Therapies for Tumor Treatment Price by Type (2016-2026) & (USD/Unit)
Figure 52. Global Gene Therapies for Tumor Treatment Sales Market Share by Application (2016-2026)
Figure 53. Global Gene Therapies for Tumor Treatment Revenue Market Share by Application (2016-2026)
Figure 54. Global Gene Therapies for Tumor Treatment Price by Application (2016-2026) & (USD/Unit)
Figure 55. North America Gene Therapies for Tumor Treatment Sales Market Share by Country (2016-2026)
Figure 56. North America Gene Therapies for Tumor Treatment Revenue Market Share by Country (2016-2026)
Figure 57. North America Gene Therapies for Tumor Treatment Sales Market Share by Type (2016-2026)
Figure 58. North America Gene Therapies for Tumor Treatment Sales Market Share by Application (2016-2026)
Figure 59. Europe Gene Therapies for Tumor Treatment Sales Market Share by Country (2016-2026)
Figure 60. Europe Gene Therapies for Tumor Treatment Revenue Market Share by Country (2016-2026)
Figure 61. Europe Gene Therapies for Tumor Treatment Sales Market Share by Type (2016-2026)
Figure 62. Europe Gene Therapies for Tumor Treatment Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific Gene Therapies for Tumor Treatment Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Gene Therapies for Tumor Treatment Revenue Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Gene Therapies for Tumor Treatment Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Gene Therapies for Tumor Treatment Sales Market Share by Application (2016-2026)
Figure 67. South America Gene Therapies for Tumor Treatment Sales Market Share by Country (2016-2026)
Figure 68. South America Gene Therapies for Tumor Treatment Revenue Market Share by Country (2016-2026)
Figure 69. South America Gene Therapies for Tumor Treatment Sales Market Share by Type (2016-2026)
Figure 70. South America Gene Therapies for Tumor Treatment Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa Gene Therapies for Tumor Treatment Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Gene Therapies for Tumor Treatment Revenue Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Gene Therapies for Tumor Treatment Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Gene Therapies for Tumor Treatment Sales Market Share by Application (2016-2026)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source
がんセラピーの世界市場予測 2023年：メーカー別、地域別、種類・用途別 Cancer therapy describes the treatment of cancer in a patient, often with surgery, chemotherapy and/or radiotherapy. Targeted therapies are also available for some cancer types. A cancer patient might receive many different types of therapy, including those aimed at relieving the symptoms of cancer,…- ムコ多糖症の遺伝子治療の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Mucopolysaccharidosis consists of a group of more than 40 genetic disorders that forms a part of lysosomal storage disease. They are caused by an inherited deficiency of an enzyme involved in the degradation of acid glycosaminoglycans (GAGs), which was previously known as mucopolysaccharidosis. All …
- 卵巣がんの遺伝子治療の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Ovarian cancer occurs and arises from several types of cells within the ovary, and it has the lowest survival rate of all gynecological cancers. Among many types, epithelial ovarian cancer (EOC) is the most common ovarian cancer, whereas ovarian low malignant potential tumor (OLMPT), germ cell tumor…
- 加齢黄斑変性症遺伝子治療の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Macular degeneration is a condition in which, macula, a part of the retina, gets damaged or deteriorated. This condition usually affects individuals who are aged 50 years and above and therefore, it is called age-related macular degeneration (AMD). AMD is the leading cause of vision loss and is dire…
- 世界の遺伝子シーケンサー市場 2021：企業別、地域別、種類・用途別 The Gene Sequencer market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, rec…